Tapewire

NYSE · USD

CAH

CARDINAL HEALTH INC

Export transactions ↓
Tapewire entity
3014
SEC CIK
0000721371
Parsed reports
455

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202604
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026031
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2021 Filed Apr 7, 2021 11:28 UTC Amendment
Mayer Jessica LChief Legal/Compliance Officer
Tax withholdingCommon Shares 911 $57.35 $52,245.85
Disclosure

SEC source: 0000721371-21-000028 · wf-form4a_161779485706487.xml · nonDerivative · entry 1

Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,166

F1 · balance_after: The number of shares beneficially owned following the reported transaction in the reporting person's Form 4 filed on March 16, 2021 was erroneously understated by 36,461 shares. The correct number of shares beneficially owned following the reported transaction that should have been reported in that Form 4 was 48,166. The number of shares beneficially owned following the reported transaction in the reporting person's Form 4 filed on March 1, 2021 was also erroneously understated by 36,461 shares. The correct number of shares beneficially owned following the reported transaction that should have been reported in that Form 4 was 49,077.

Read SEC document
February 26, 2021 Filed Mar 1, 2021 21:16 UTC
Mayer Jessica LChief Legal/Compliance Officer
SaleCommon Shares 3,500 $51.53 $180,355.00
Disclosure

SEC source: 0000721371-21-000017 · wf-form4_161463335130300.xml · nonDerivative · entry 1

Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,616

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.44 to $51.69, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.

F2 · balance_after: Since the date of the reporting person's last ownership report, she transferred 6,853 common shares and employee stock options to purchase 12,048 common shares to her ex-spouse pursuant to a domestic relations order entered in December 2020.

Read SEC document
February 15, 2021 Filed Feb 16, 2021 12:18 UTC
Rice Brian SChief Information Officer
Tax withholdingCommon Shares 1,353 $51.86 $70,166.58
Disclosure

SEC source: 0000721371-21-000015 · wf-form4_161347788661205.xml · nonDerivative · entry 1

Rice Brian S · CIK 0001767478 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,934

F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 4,206 restricted share units.

F2 · price: Reflects closing price on prior business day.

Read SEC document
February 11, 2021 Filed Feb 12, 2021 13:31 UTC
English Patricia MChief Accounting Officer
SaleCommon Shares 3,291 $51.98 $171,066.18
Disclosure

SEC source: 0000721371-21-000013 · wf-form4_161313666047957.xml · nonDerivative · entry 1

English Patricia M · CIK 0001823407 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,085

Read SEC document
January 15, 2021 Filed Jan 19, 2021 12:56 UTC GrantPhantom Stock · Derivative 519 $55.39 $28,747.41
Disclosure

SEC source: 0000721371-21-000004 · wf-form4_161106100271230.xml · derivative · entry 1

SCARBOROUGH DEAN A · CIK 0001197584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,918

Underlying: Common Shares · 519 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F2 · price: Reflects closing price on prior business day.

F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

Read SEC document
January 15, 2021 Filed Jan 19, 2021 12:56 UTC GrantPhantom Stock · Derivative 560 $55.39 $31,018.40
Disclosure

SEC source: 0000721371-21-000003 · wf-form4_161106096819816.xml · derivative · entry 1

LOSH J MICHAEL · CIK 0001199190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,506

Underlying: Common Shares · 560 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F2 · price: Reflects closing price on prior business day.

F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 12:39 UTC
Kaufmann Michael CDirector · CEO
Tax withholdingCommon Shares 3,206 $54.59 $175,015.54
Disclosure

SEC source: 0000721371-20-000163 · wf-form4_160691277251721.xml · nonDerivative · entry 1

Kaufmann Michael C · CIK 0001471294 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,529

F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units.

F2 · price: Reflects closing price on prior business day.

Read SEC document
November 15, 2020 Filed Nov 17, 2020 12:19 UTC
CRAWFORD VICTOR L.CEO, Pharmaceutical Segment
Tax withholdingCommon Shares 4,362 $57.43 $250,509.66
Disclosure

SEC source: 0000721371-20-000161 · wf-form4_160561556881050.xml · nonDerivative · entry 1

CRAWFORD VICTOR L. · CIK 0001449780 · CEO, Pharmaceutical Segment

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,124

F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 8,676 restricted share units.

F2 · price: Reflects closing price on prior business day.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:41 UTC
JOHRI AKHILDirector
GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000158 · wf-form4_160504447191726.xml · nonDerivative · entry 1

JOHRI AKHIL · CIK 0001517450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,089

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:40 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000157 · wf-form4_160504442270493.xml · nonDerivative · entry 1

WEILAND JOHN H · CIK 0001204663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,429

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:39 UTC
DOWNEY BRUCEDirector
GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000156 · wf-form4_160504438095364.xml · nonDerivative · entry 1

DOWNEY BRUCE · CIK 0001237257 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,912

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:37 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000154 · wf-form4_160504424926763.xml · nonDerivative · entry 1

DARDEN CALVIN · CIK 0001227732 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,616

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:39 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000155 · wf-form4_160504433375630.xml · nonDerivative · entry 1

Hall Patricia Hemingway · CIK 0001517890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,485

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:37 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000153 · wf-form4_160504421684230.xml · nonDerivative · entry 1

Evans David C · CIK 0001375909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,594

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:36 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000152 · wf-form4_160504418433550.xml · nonDerivative · entry 1

LOSH J MICHAEL · CIK 0001199190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,988

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:36 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000151 · wf-form4_160504415087273.xml · nonDerivative · entry 1

Killefer Nancy · CIK 0001584637 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,845

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:35 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000150 · wf-form4_160504411372164.xml · nonDerivative · entry 1

SCARBOROUGH DEAN A · CIK 0001197584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,429

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:34 UTC GrantCommon Shares 5,595 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000149 · wf-form4_160504407390305.xml · nonDerivative · entry 1

KENNY GREGORY B · CIK 0001179497 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,405

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:34 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000148 · wf-form4_160504403303323.xml · nonDerivative · entry 1

Edison Sheri H. · CIK 0001413612 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,069

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:33 UTC GrantCommon Shares 3,339 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000147 · wf-form4_160504397837010.xml · nonDerivative · entry 1

COX CARRIE SMITH · CIK 0001110753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,614

F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.

Read SEC document
November 08, 2020 Filed Nov 10, 2020 21:41 UTC
Kaufmann Michael CDirector · CEO
Tax withholdingCommon Shares 6,485 $52.64 $341,370.40
Disclosure

SEC source: 0000721371-20-000159 · wf-form4_160504450495730.xml · nonDerivative · entry 1

Kaufmann Michael C · CIK 0001471294 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 447,735

F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 15,562 restricted share units.

F2 · price: Reflects closing price on prior business day.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 13:07 UTC
Snow Ola MChief Human Resources Officer
Tax withholdingCommon Shares 593 $48.37 $28,683.41
Disclosure

SEC source: 0000721371-20-000126 · wf-form4_160311286339160.xml · nonDerivative · entry 1

Snow Ola M · CIK 0001754463 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,889

F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,617 restricted share units.

F2 · price: Reflects closing price on prior business day.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 13:06 UTC GrantPhantom Stock · Derivative 594 $48.37 $28,731.78
Disclosure

SEC source: 0000721371-20-000125 · wf-form4_160311275485983.xml · derivative · entry 1

SCARBOROUGH DEAN A · CIK 0001197584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,399

Underlying: Common Shares · 594 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F2 · price: Reflects closing price on prior business day.

F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 13:05 UTC GrantPhantom Stock · Derivative 723 $48.37 $34,971.51
Disclosure

SEC source: 0000721371-20-000124 · wf-form4_160311270655913.xml · derivative · entry 1

LOSH J MICHAEL · CIK 0001199190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,937

Underlying: Common Shares · 723 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F2 · price: Reflects closing price on prior business day.

F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

Read SEC document
September 15, 2020 Filed Sep 17, 2020 13:06 UTC GrantCommon Shares 730 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000117 · wf-form4_160034796792780.xml · nonDerivative · entry 1

Edison Sheri H. · CIK 0001413612 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 730

F1 · shares: Grant of restricted share units that will vest on September 15, 2021.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:49 UTC
Snow Ola MChief Human Resources Officer
Tax withholdingCommon Shares 1,911 $53.68 $102,582.48
Disclosure

SEC source: 0000721371-20-000107 · wf-form4_159769736441461.xml · nonDerivative · entry 2

Snow Ola M · CIK 0001754463 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,482

F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 5,999 RSUs and 238 performance share units.

F3 · price: Reflects closing price on prior business day.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:49 UTC
Snow Ola MChief Human Resources Officer
GrantCommon Shares 11,177 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000107 · wf-form4_159769736441461.xml · nonDerivative · entry 1

Snow Ola M · CIK 0001754463 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,393

F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2021.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:45 UTC
Holcomb MicheleEVP - Strategy & Corp. Dev.
Tax withholdingCommon Shares 2,289 $53.68 $122,873.52
Disclosure

SEC source: 0000721371-20-000105 · wf-form4_159769710544518.xml · nonDerivative · entry 2

Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,783

F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 6,851 RSUs and 810 performance share units.

F3 · price: Reflects closing price on prior business day.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:45 UTC
Holcomb MicheleEVP - Strategy & Corp. Dev.
GrantCommon Shares 7,452 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000105 · wf-form4_159769710544518.xml · nonDerivative · entry 1

Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,072

F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2021.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:41 UTC
Mason Stephen MCEO, Medical Segment
Tax withholdingCommon Shares 3,290 $53.68 $176,607.20
Disclosure

SEC source: 0000721371-20-000103 · wf-form4_159769686506604.xml · nonDerivative · entry 2

Mason Stephen M · CIK 0001786065 · CEO, Medical Segment

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,797

F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 10,583 RSUs and 429 performance share units.

F3 · price: Reflects closing price on prior business day.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:41 UTC
Mason Stephen MCEO, Medical Segment
GrantCommon Shares 18,629 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000103 · wf-form4_159769686506604.xml · nonDerivative · entry 1

Mason Stephen M · CIK 0001786065 · CEO, Medical Segment

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,087

F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2021.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:34 UTC
Rice Brian SChief Information Officer
Tax withholdingCommon Shares 972 $53.68 $52,176.96
Disclosure

SEC source: 0000721371-20-000099 · wf-form4_159769642888591.xml · nonDerivative · entry 2

Rice Brian S · CIK 0001767478 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,287

F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 3,174 RSUs.

F3 · price: Reflects closing price on prior business day.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:34 UTC
Rice Brian SChief Information Officer
GrantCommon Shares 7,452 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000099 · wf-form4_159769642888591.xml · nonDerivative · entry 1

Rice Brian S · CIK 0001767478 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,259

F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2021.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:37 UTC
Hollar Jason M.Chief Financial Officer
GrantCommon Shares 18,629 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000101 · wf-form4_159769662752265.xml · nonDerivative · entry 1

Hollar Jason M. · CIK 0001687858 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,058

F1 · kind: Grant of restricted share units that vest in three equal annual installments beginning on August 15, 2021.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:22 UTC
Kaufmann Michael CDirector · CEO
Tax withholdingCommon Shares 26,775 $53.68 $1,437,282.00
Disclosure

SEC source: 0000721371-20-000095 · wf-form4_159769571028811.xml · nonDerivative · entry 2

Kaufmann Michael C · CIK 0001471294 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 454,220

F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 58,925 RSUs and 2,717 performance share units.

F3 · price: Reflects closing price on prior business day.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:22 UTC
Kaufmann Michael CDirector · CEO
GrantCommon Shares 74,516 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000095 · wf-form4_159769571028811.xml · nonDerivative · entry 1

Kaufmann Michael C · CIK 0001471294 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 480,995

F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2021.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:30 UTC
Mayer Jessica LChief Legal/Compliance Officer
Tax withholdingCommon Shares 2,793 $53.68 $149,928.24
Disclosure

SEC source: 0000721371-20-000097 · wf-form4_159769619918182.xml · nonDerivative · entry 2

Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,430

F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 8,920 RSUs and 429 performance share units.

F3 · price: Reflects closing price on prior business day.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:30 UTC
Mayer Jessica LChief Legal/Compliance Officer
GrantCommon Shares 13,785 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000097 · wf-form4_159769619918182.xml · nonDerivative · entry 1

Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,223

F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2021.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:13 UTC
LAWS STUART GSVP & Chief Accounting Officer
Tax withholdingCommon Shares 1,074 $53.68 $57,652.32
Disclosure

SEC source: 0000721371-20-000091 · wf-form4_159769517342937.xml · nonDerivative · entry 1

LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,289

F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 3,337 restricted share units and 401 performance share units.

F2 · price: Reflects closing price on prior business day.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:17 UTC
CRAWFORD VICTOR L.CEO, Pharmaceutical Segment
Tax withholdingCommon Shares 3,080 $53.68 $165,334.40
Disclosure

SEC source: 0000721371-20-000093 · wf-form4_159769544132583.xml · nonDerivative · entry 2

CRAWFORD VICTOR L. · CIK 0001449780 · CEO, Pharmaceutical Segment

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,486

F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 8,730 RSUs.

F3 · price: Reflects closing price on prior business day.

Read SEC document
August 15, 2020 Filed Aug 17, 2020 20:17 UTC
CRAWFORD VICTOR L.CEO, Pharmaceutical Segment
GrantCommon Shares 20,492 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000093 · wf-form4_159769544132583.xml · nonDerivative · entry 1

CRAWFORD VICTOR L. · CIK 0001449780 · CEO, Pharmaceutical Segment

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,566

F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2021.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 21:37 UTC
Snow Ola MChief Human Resources Officer
GrantCommon Shares 238 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000082 · wf-form4_159657694687793.xml · nonDerivative · entry 1

Snow Ola M · CIK 0001754463 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,216

F1 · kind: Reflects performance share units that will settle on August 15, 2020.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 21:34 UTC
Mayer Jessica LChief Legal/Compliance Officer
GrantCommon Shares 429 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000081 · wf-form4_159657664240470.xml · nonDerivative · entry 1

Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,438

F1 · kind: Reflects performance share units that will settle on August 15, 2020.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 21:30 UTC
LAWS STUART GSVP & Chief Accounting Officer
GrantCommon Shares 401 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000080 · wf-form4_159657636207580.xml · nonDerivative · entry 1

LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,363

F1 · kind: Reflects performance share units that will settle on August 15, 2020.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 21:21 UTC
Mason Stephen MCEO, Medical Segment
GrantCommon Shares 429 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000079 · wf-form4_159657596459577.xml · nonDerivative · entry 1

Mason Stephen M · CIK 0001786065 · CEO, Medical Segment

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,458

F1 · kind: Reflects performance share units that will settle on August 15, 2020.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 21:15 UTC
Kaufmann Michael CDirector · CEO
GrantCommon Shares 2,717 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000078 · wf-form4_159657556472792.xml · nonDerivative · entry 1

Kaufmann Michael C · CIK 0001471294 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,479

F1 · kind: Reflects performance share units that will settle on August 15, 2020.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 21:13 UTC
Holcomb MicheleEVP - Strategy & Corp. Dev.
GrantCommon Shares 810 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000077 · wf-form4_159657534330421.xml · nonDerivative · entry 1

Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,620

F1 · kind: Reflects performance share units that will settle on August 15, 2020.

Read SEC document
July 15, 2020 Filed Jul 16, 2020 20:51 UTC GrantCommon Shares 1,255 $0.00 $0.00
Disclosure

SEC source: 0000721371-20-000067 · wf-form4_159493265599254.xml · nonDerivative · entry 1

Evans David C · CIK 0001375909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,255

F1 · shares: Grant of restricted share units that will vest on July 15, 2021.

Read SEC document
July 15, 2020 Filed Jul 16, 2020 20:50 UTC GrantPhantom Stock · Derivative 564 $50.93 $28,724.52
Disclosure

SEC source: 0000721371-20-000066 · wf-form4_159493260888790.xml · derivative · entry 1

SCARBOROUGH DEAN A · CIK 0001197584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,812

Underlying: Common Shares · 564 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F2 · price: Reflects closing price on prior business day.

F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

Read SEC document
July 15, 2020 Filed Jul 16, 2020 20:49 UTC GrantPhantom Stock · Derivative 687 $50.93 $34,988.91
Disclosure

SEC source: 0000721371-20-000065 · wf-form4_159493253846586.xml · derivative · entry 1

LOSH J MICHAEL · CIK 0001199190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,219

Underlying: Common Shares · 687 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F2 · price: Reflects closing price on prior business day.

F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.